Friday’s Most Buzzworthy Stocks: Antero, Valeant, Southwestern Energy, More

Page 2 of 2

Valeant Considering Selling a Unit

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is in the spotlight after news broke that the beleaguered pharmaceutical company is considering selling its Amoun Pharmaceutical unit. Valeant bought Amoun for $800 million last year and a sale could help lower Wall Street’s concerns about the company’s debt. Amoun is the largest pharmaceutical company in Egypt and counts antibiotics, blood pressure medications, and veterinary medicines as part of its portfolio. Valeant is being advised by Goldman on the potential sale. The sale of the unit is at a preliminary stage and there is no guarantee of a deal. Bill Ackman‘s Pershing Square is one of the top shareholders of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and the billionaire hedge fund manager is working hard behind the scenes to turn the company around.

Follow Bausch Health Companies Inc. (NYSE:BHC)

Sophiris Bio Spikes on Study

Nano-cap Sophiris Bio Inc (NASDAQ:SPHS) is over 105% higher this morning after a Phase 2a clinical trial showed that the company’s lead drug candidate for the treatment of localized prostate cancer, PRX302, had a response rate of 50% and was well-tolerated. Due to the results, Sophiris plans to continue with the development of the drug, which is also called topsalysin. Sophiris Bio Inc (NASDAQ:SPHS) was in the portfolio of four elite funds in our database at the end of March. As with all nano-caps, investors should perform due-diligence before trading in it.

Disclosure: None

Page 2 of 2